Trump’s Back, but DC’s Coming for Your Money!

Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy with a heavy hand—building up infrastructure, slapping tariffs on imports, and going all-in on U.S. jobs. But here's the kicker: while Trump's focused on making America stronger, the Washington elite is ready to fight back…

Get ahead of the game with 3 proven strategies to protect your retirement from Washington's next mov

TARA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 12.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $891,116.44

Protara Therapeutics Insider Trading History Chart

Protara Therapeutics Share Price & Price History

^$2.60

▼ -0.09 (-3.35%)

As of 11/14/2024 03:30 PM ET

Days: 30 | 90 | 365

There is a little known company that is changing warfare

From Reticulate | Ad

With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military.

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

Protara Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
9/11/2024	Opaleye Management Inc.	Major Shareholder	Sell	32,600	$1.71	$55,746.00	51,500
9/9/2024	Opaleye Management Inc.	Major Shareholder	Sell	36,492	$1.89	$68,969.88	54,600
7/16/2024	Opaleye Management Inc.	Major Shareholder	Sell	11,396	$2.44	$27,806.24	56,500
7/11/2024	Opaleye Management Inc.	Major Shareholder	Sell	47,993	$2.40	$115,183.20	60,000
7/9/2024	Opaleye Management Inc.	Major Shareholder	Sell	8,497	$2.21	$18,778.37	80,000
7/1/2024	Opaleye Management Inc.	Major Shareholder	Sell	8,288	$2.12	$17,570.56	87,500
6/27/2024	Opaleye Management Inc.	Major Shareholder	Sell	46,574	$2.26	$105,257.24	90,000
6/25/2024	Opaleye Management Inc.	Major Shareholder	Sell	12,725	$2.26	$28,758.50	102,471
5/30/2024	Opaleye Management Inc.	Major Shareholder	Sell	9,230	$2.94	$27,136.20	114,520
5/21/2024	Opaleye Management Inc.	Major Shareholder	Sell	33,000	$3.06	$100,980.00	124,250
5/17/2024	Opaleye Management Inc.	Major Shareholder	Sell	70,885	$3.25	$230,376.25	126,050
5/9/2024	Opaleye Management Inc.	Major Shareholder	Sell	30,600	$3.09	$94,554.00	2,531,994
9/14/2022	Opaleye Management Inc.	Major Shareholder	Buy	16,600	$3.98	$66,068.00	2,570,777
8/11/2022	Jesse Shefferman	CEO	Buy	9,065	$3.84	$34,809.60	879,441
6/30/2022	Luke M Beshar	Director	Buy	10,000	$3.10	$31,000.00	198,000
4/7/2022	Opaleye Management Inc.	Major Shareholder	Buy	2,345	$4.74	$11,115.30
3/14/2022	Luke M Beshar	Director	Buy	10,000	$4.25	$42,500.00
3/10/2022	Luke M Beshar	Director	Buy	10,000	$4.46	$44,600.00
1/28/2022	Opaleye Management Inc.	Major Shareholder	Buy	24,031	$4.96	$119,193.76
12/29/2021	Opaleye Management Inc.	Major Shareholder	Buy	4,500	$6.98	$31,410.00
12/27/2021	Opaleye Management Inc.	Major Shareholder	Buy	36,700	$6.53	$239,651.00
12/23/2021	Opaleye Management Inc.	Major Shareholder	Buy	1,300	$6.60	$8,580.00
12/20/2021	Opaleye Management Inc.	Major Shareholder	Buy	703	$6.49	$4,562.47
12/16/2021	Opaleye Management Inc.	Major Shareholder	Buy	7,563	$6.41	$48,478.83
11/17/2021	Opaleye Management Inc.	Major Shareholder	Buy	9,118	$6.98	$63,643.64

There is a little known company that is changing warfare

From Reticulate | Ad

Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t

SEC Filings (Institutional Ownership Changes) for Protara Therapeutics (NASDAQ:TARA)

38.13% of Protara Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Protara Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/6/2024	Oppenheimer & Co. Inc.	179,125	$0.33M	0.0%	+40.8%	0.868%
8/15/2024	CVI Holdings LLC	302,746	$0.63M	0.6%	N/A	1.468%
8/15/2024	Armistice Capital LLC	520,000	$1.08M	0.0%	N/A	2.521%
8/14/2024	Marshall Wace LLP	77,351	$0.16M	0.0%	N/A	0.375%
8/9/2024	Renaissance Technologies LLC	150,400	$0.31M	0.0%	+77.8%	0.730%
8/2/2024	Privium Fund Management UK Ltd	114,708	$0.23M	0.1%	-4.2%	0.557%
5/17/2024	Ikarian Capital LLC	202,701	$0.81M	0.1%	+7.4%	0.984%
5/7/2024	Oppenheimer & Co. Inc.	10,000	$40K	0.0%	N/A	0.087%
11/6/2023	Assenagon Asset Management S.A.	15,831	$26K	0.0%	-45.5%	0.140%
7/26/2023	Privium Fund Management B.V.	119,730	$0.27M	0.1%	N/A	1.059%
7/25/2023	Assenagon Asset Management S.A.	29,051	$69K	0.0%	+67.6%	0.257%
2/10/2023	Opaleye Management Inc.	2,692,594	$7.22M	2.5%	-0.6%	23.892%
2/9/2023	Privium Fund Management UK Ltd	119,730	$0.32M	0.2%	+242.1%	1.062%
1/12/2023	Assenagon Asset Management S.A.	17,336	$46K	0.0%	-70.3%	0.154%
11/14/2022	Boothbay Fund Management LLC	18,864	$56K	0.0%	-26.5%	0.167%
11/1/2022	Privium Fund Management UK Ltd	35,000	$0.10M	0.1%	N/A	0.311%
8/15/2022	Opaleye Management Inc.	2,684,167	$8.89M	4.0%	+0.4%	23.823%
8/12/2022	Ikarian Capital LLC	257,853	$0.76M	0.1%	-13.0%	2.292%
8/12/2022	DLD Asset Management LP	157,349	$0.46M	0.0%	-31.4%	1.396%
7/27/2022	Assenagon Asset Management S.A.	58,389	$0.17M	0.0%	+33.5%	0.519%
4/25/2022	Assenagon Asset Management S.A.	43,741	$0.22M	0.0%	N/A	0.389%
2/22/2022	DLD Asset Management LP	229,231	$1.55M	0.1%	N/A	2.040%
2/15/2022	Sender Co & Partners Inc.	28,502	$0.19M	0.1%	N/A	0.254%
2/15/2022	DLD Asset Management LP	229,231	$1.55M	0.1%	N/A	2.040%
2/14/2022	Opaleye Management Inc.	2,650,000	$18M	3.8%	+3.6%	23.585%
2/10/2022	Acadian Asset Management LLC	17,219	$0.12M	0.0%	N/A	0.153%
11/16/2021	Two Sigma Advisers LP	168,818	$1.17M	0.0%	+189.5%	1.502%
11/16/2021	Two Sigma Investments LP	130,935	$0.91M	0.0%	+136.3%	1.165%
11/15/2021	Marshall Wace LLP	15,190	$0.11M	0.0%	-13.0%	0.135%
11/12/2021	Trexquant Investment LP	12,454	$86K	0.0%	N/A	0.111%
11/12/2021	Renaissance Technologies LLC	115,900	$0.80M	0.0%	+125.4%	1.032%
11/12/2021	Jump Financial LLC	14,500	$100K	0.0%	N/A	0.129%
11/10/2021	Goldman Sachs Group Inc.	155,973	$1.08M	0.0%	+17.9%	1.388%
11/9/2021	BlackRock Inc.	44,036	$0.31M	0.0%	+9.7%	0.392%
8/25/2021	Marshall Wace LLP	17,469	$0.17M	0.0%	-58.5%	0.155%
8/18/2021	Ikarian Capital LLC	584,804	$5.70M	0.5%	-10.0%	5.205%
8/17/2021	Millennium Management LLC	129,380	$1.26M	0.0%	+115.2%	1.151%
8/16/2021	State Street Corp	10,359	$0.10M	0.0%	-82.8%	0.092%
8/16/2021	Goldman Sachs Group Inc.	132,257	$1.29M	0.0%	N/A	1.177%
8/16/2021	Marshall Wace LLP	17,469	$0.17M	0.0%	-58.5%	0.155%
8/13/2021	Renaissance Technologies LLC	51,427	$0.50M	0.0%	+63.8%	0.458%
8/13/2021	Northern Trust Corp	22,279	$0.22M	0.0%	-60.7%	0.198%
8/13/2021	Knott David M	36,164	$0.35M	0.1%	+151.7%	0.322%
8/13/2021	Geode Capital Management LLC	82,985	$0.81M	0.0%	-25.3%	0.739%
8/13/2021	Vanguard Group Inc.	437,108	$4.26M	0.0%	-4.3%	3.890%
8/12/2021	Ergoteles LLC	17,700	$0.17M	0.0%	N/A	0.158%
8/11/2021	Bank of New York Mellon Corp	17,907	$0.17M	0.0%	-30.3%	0.159%
8/11/2021	Susquehanna International Group LLP	20,609	$0.20M	0.0%	N/A	0.184%
6/10/2021	Perceptive Advisors LLC	421,642	$6.64M	0.1%	-30.7%	3.755%
5/18/2021	Millennium Management LLC	60,134	$0.95M	0.0%	+8.8%	0.536%
5/18/2021	Alyeska Investment Group L.P.	109,405	$1.72M	0.0%	+47.0%	0.974%
5/18/2021	Citadel Advisors LLC	241,514	$3.80M	0.0%	N/A	2.151%
5/17/2021	Schonfeld Strategic Advisors LLC	23,455	$0.37M	0.0%	N/A	0.209%
5/17/2021	Perceptive Advisors LLC	421,642	$6.64M	0.1%	-30.7%	3.755%
5/17/2021	Rock Springs Capital Management LP	689,942	$10.86M	0.2%	+7.3%	6.144%
5/17/2021	Price T Rowe Associates Inc. MD	319,326	$5.03M	0.0%	-26.4%	2.844%
5/17/2021	Nuveen Asset Management LLC	13,940	$0.22M	0.0%	-43.4%	0.124%
5/13/2021	Renaissance Technologies LLC	31,400	$0.49M	0.0%	+83.5%	0.280%
5/13/2021	Bank of Montreal Can	61,742	$0.95M	0.0%	+9,988.6%	0.550%
5/12/2021	Northern Trust Corp	56,676	$0.89M	0.0%	-10.3%	0.505%
5/12/2021	Geode Capital Management LLC	111,062	$1.75M	0.0%	+5.9%	0.989%
5/12/2021	Panagora Asset Management Inc.	5,921	$93K	0.0%	N/A	0.053%
5/11/2021	Artisan Partners Limited Partnership	379,946	$5.98M	0.0%	+0.9%	3.384%
5/7/2021	BlackRock Inc.	189,876	$2.99M	0.0%	+4.4%	1.691%
2/24/2021	Alyeska Investment Group L.P.	74,405	$1.80M	0.0%	-62.8%	0.664%
2/16/2021	Tri Locum Partners LP	39,225	$0.95M	0.3%	N/A	0.350%
2/16/2021	Alyeska Investment Group L.P.	74,405	$1.80M	0.0%	-62.8%	0.664%
2/16/2021	Nuveen Asset Management LLC	24,647	$0.60M	0.0%	N/A	0.220%
2/16/2021	Price T Rowe Associates Inc. MD	433,598	$10.50M	0.0%	-3.2%	3.867%
2/16/2021	Charles Schwab Investment Management Inc.	12,060	$0.29M	0.0%	N/A	0.108%
2/13/2021	American International Group Inc.	2,249	$54K	0.0%	+86.5%	0.020%
2/12/2021	Ikarian Capital LLC	649,542	$15.73M	0.7%	-10.1%	5.793%
2/11/2021	Northern Trust Corp	63,212	$1.53M	0.0%	+71.3%	0.564%
2/10/2021	Renaissance Technologies LLC	17,110	$0.41M	0.0%	-54.7%	0.153%
2/10/2021	Artisan Partners Limited Partnership	376,733	$9.12M	0.0%	+27.1%	3.360%
2/9/2021	Wells Fargo & Company MN	13,110	$0.32M	0.0%	-20.8%	0.117%
2/9/2021	Bank of New York Mellon Corp	25,142	$0.61M	0.0%	N/A	0.224%
2/5/2021	BlackRock Inc.	181,888	$4.40M	0.0%	+97.2%	1.622%
12/30/2020	Deerfield Management Company L.P. Series C	782,670	$13.17M	0.3%	+80.9%	6.981%
11/16/2020	Perceptive Advisors LLC	608,544	$10.24M	0.1%	N/A	10.388%
11/16/2020	Boothbay Fund Management LLC	64,683	$1.09M	0.1%	+46.9%	1.104%
11/10/2020	State Street Corp	23,018	$0.39M	0.0%	+26.8%	0.393%
11/10/2020	TD Asset Management Inc.	25,185	$0.42M	0.0%	N/A	0.430%
11/5/2020	Wells Fargo & Company MN	16,563	$0.28M	0.0%	+89.0%	0.283%

Data available starting January 2016

Protara Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in advancing transformative therapies for the treatment of cancer and rare diseases. The company's lead program is TARA-002, an investigational cell therapy, which is in Phase II clinical trial for the treatment of non-muscle invasive bladder cancer and lymphatic malformations. It is also developing intravenous choline chloride, an investigational phospholipid substrate replacement therapy that is in Phase II clinical trial for patients receiving parenteral nutrition. The company is headquartered in New York, New York.

Today's Range

Now: $2.60

$2.55

$2.78

50 Day Range

MA: $2.02

$1.62

$2.69

52 Week Range

Now: $2.60

$1.04

$5.24

Volume

136,748 shs

Average Volume

216,618 shs

Market Capitalization

$53.64 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.77

Who are the company insiders with the largest holdings of Protara Therapeutics?: Protara Therapeutics' top insider investors include:
Opaleye Management Inc (Major Shareholder)
Learn More about top insider investors at Protara Therapeutics.
Who are the major institutional investors of Protara Therapeutics?: Protara Therapeutics' top institutional shareholders include:
Oppenheimer & Co. Inc. — 0.87%
Learn More about top institutional investors of Protara Therapeutics stock.
Which major investors are buying Protara Therapeutics stock?: Within the previous quarter, TARA stock was purchased by institutional investors including:
Oppenheimer & Co. Inc.